Similar findings have been reported in ovarian cancer, where elevated Tim-3 on peripheral CD8+ T cells correlates with advanced disease and may promote tumor progression by driving T cell exhaustion and impairing antitumor immunity [35]. This evidence concerns the gene CD8A and ovarian carcinoma.